In 2018, Dr. Fernandez-Bravo was diagnosed with smoldering multiple myeloma. She is enrolled in a clinical trial at the Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at the Dana-Farber/Brigham and Women’s Cancer Center in Boston.
Dr. Fernandez-Bravo is used to commuting between Massachusetts and Florida for treatment, though now she drives instead of flying due to COVID-19. Because of her immunocompromised state, she has addressed supply concerns and worked on creating emergency evaluation tents at her hospital without being on-site.
Dr. Fernandez-Bravo, who describes herself as a hands-on leader, still answers around-the-clock phone calls and videoconferencing, managing her hospital from what she told Dana-Farber Cancer Institute is “an arm’s length.”
“I’m lucky because I have an amazing team who can be the boots on the ground for me,” Dr. Fernandez-Bravo said. “It’s been difficult to be away, but I am grateful I can continue to work, even if it’s at an arm’s length.”
Read the full article from the Dana-Farber Cancer Institute here.
More articles on leadership:
Tampa General CEO John Couris: The key to effectively mobilizing for COVID-19 and how to plan for the ‘new normal’
Ochsner Health’s key tactics to promote staff well-being during COVID-19
CEO of Children’s Hospital Los Angeles: 5 standout initiatives in the fight against COVID-19
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
